drugset / Trial / NCT05916508

A Bleeding-Model Clinical Study

NCT05916508 ↗

Completed 90 enrolled Procter and Gamble
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the study is to evaluate the gingivitis control benefit of an established stannous fluoride containing toothpaste relative to a negative control dentifrice.

Timeline

Start
2020-10-19
Primary completion
2020-11-20
Completion
2020-11-20

Outcome

Met primary endpoint

paper At 1 mo, the positive control produced 45.1% (study 1) and 45.8% (study 2) fewer bleeding sites versus the negative control (P < 0.001 for both), PMID 39118360 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium monofluorophosphate Unknown 0.76 % Topical
Subject stannous fluoride Small molecule 0.454 % Topical

Indications